绿catechinapolipoprotein E-null

Kuang-Yuh Chyu1, Stephanie M Babbidge, Xiaoning Zhao

  • 1Atherosclerosis Research Center, Division of Cardiology, and Department of Medicine, Cedars-Sinai Medical Center and David Geffen School of Medicine at the University of California, Los Angeles, CA 90048, USA. chyuk@cshs.org

Circulation
|May 12, 2004
PubMed
概括

绿茶中的抗氧化剂甲基甲酸 (EGCG) 有效地降低了小鼠早期动脉样硬化的发展. 然而,EGCG没有影响已确定的动脉样硬化病变,这表明时间对抗氧化剂治疗的有效性至关重要.